Sonidegib after vismodegib discontinuation in a patient with Gorlin-Goltz syndrome and multiple basal cell carcinomas

Dermatol Ther. 2021 Sep;34(5):e15095. doi: 10.1111/dth.15095. Epub 2021 Aug 19.

Authors

Alfredo Piccerillo^{1

2}, Alessandro Di Stefani^{1

2}, Alessio Costantini^{1

2}, Ketty Peris^{1

2}

Affiliations

¹ Institute of Dermatology, Università Cattolica del Sacro Cuore, Rome, Italy.
² Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Anilides
Basal Cell Nevus Syndrome* / diagnosis
Basal Cell Nevus Syndrome* / drug therapy
Biphenyl Compounds
Carcinoma, Basal Cell* / drug therapy
Female
Hamartoma Syndrome, Multiple
Humans
Pyridines

Substances

Anilides
Biphenyl Compounds
HhAntag691
Pyridines
sonidegib

Supplementary concepts

Basal cell carcinoma, multiple